Vasa Previa

Vasa previa occurs when unprotected fetal blood vessels — part of a velamentous cord insertion or accessory placental lobe — cross the internal cervical os beneath the presenting fetal part, and USMLE Step 1 tests this as a high-stakes clinical scenario where recognizing the mechanism is the difference between answering correctly and falling into a trap. The critical concept is that these vessels have no Wharton's jelly or placental tissue protecting them. When membranes rupture, those vessels rupture too, and because the blood is fetal in origin, even a small hemorrhage is catastrophic. The exam typically presents a vignette with painless vaginal bleeding after membrane rupture, followed by sudden fetal bradycardia — and expects you to identify this as a fetal emergency, not a maternal bleeding problem like placenta previa.

The most common mistake students make is conflating vasa previa with placenta previa because both involve bleeding near the os. But the source of bleeding is completely different: placenta previa bleeding is maternal, vasa previa bleeding is fetal. A fetus has roughly 250 mL of total blood volume — losing even 100 mL is immediately life-threatening. This is why fetal bradycardia follows so rapidly after membrane rupture in vasa previa cases.

USMLE Step 1 also tests management, and this is where another misconception bites students. Vasa previa is not managed like a 'wait and see' obstetric condition. If diagnosed prenatally — typically by color Doppler ultrasound — the standard of care is planned cesarean delivery at 34–37 weeks, before spontaneous labor or membrane rupture can trigger fetal exsanguination. Questions testing management will reward students who understand that the entire goal is to prevent the fetal vessels from ever being exposed to the shear forces of rupture.